Brucella antigen

Sanitop® is made from a durable rubber compound formed with an alternating large and small hole drainage system to keep liquid and debris free from the work area. Designed to withstand harsh chemicals while creating a slip resistant surface,

Sanitop® is made from a durable rubber compound formed with an alternating large and small hole drainage system to keep liquid and debris free from the work area. Designed to withstand harsh chemicals while creating a slip resistant surface,

Sanitop® is made from a durable rubber compound formed with an alternating large and small hole drainage system to keep liquid and debris free from the work area. Designed to withstand harsh chemicals while creating a slip resistant surface,

Sanitop® is made from a durable rubber compound formed with an alternating large and small hole drainage system to keep liquid and debris free from the work area. Designed to withstand harsh chemicals while creating a slip resistant surface,

Sanitop® is made from a durable rubber compound formed with an alternating large and small hole drainage system to keep liquid and debris free from the work area. Designed to withstand harsh chemicals while creating a slip resistant surface,

Mouse anti Human ABCB5 Antibody, Monoclonal (CHS11A2), could be used for WB, IHC and so on.

Mouse anti Human ABCB5 Antibody, Monoclonal (CHS11A2), could be used for WB, IHC and so on.

Mouse anti Human ABCB5 Antibody, Monoclonal (CHS11A2), could be used for WB, IHC and so on.

Mouse anti Human ABCB5 Antibody, Monoclonal (CHS11A2), could be used for WB, IHC and so on.

Abelacimab (anti-Factor XI) is a fully human IgG1 monoclonal antibody that binds with high affinity to the catalytic structural domain of FXI and locks it in the zymogen conformation, thereby preventing its activation by FXIIa or thrombin.

Abelacimab (anti-Factor XI) is a fully human IgG1 monoclonal antibody that binds with high affinity to the catalytic structural domain of FXI and locks it in the zymogen conformation, thereby preventing its activation by FXIIa or thrombin.

Abelacimab (anti-Factor XI) is a fully human IgG1 monoclonal antibody that binds with high affinity to the catalytic structural domain of FXI and locks it in the zymogen conformation, thereby preventing its activation by FXIIa or thrombin.